Hou F - Search Results

1

China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysis.

Hou F, Jiang J, Chen J, Yu X, Zhou Q, Chen P, Mei C, Xiong F, Shi W, Zhou W, Liu X, Sun S, Xie D, Liu J, Zhang P, Yang X, Zhang Y, Zhang Y, Liang X, Zhang Z, Lin Q, Yu Y, Wu S, Xu X. Hou F, et al. BMC Nephrol. 2012 Aug 30;13:94. doi: 10.1186/1471-2369-13-94. BMC Nephrol. 2012. PMID: 22935444 Free PMC article. Clinical Trial.

2

[Expression of Fas on monocytes and the level of plasma soluble FasL in patients with chronic renal failure].

Jiang J, Hou F, Liu Z, Liu J, Zhang X. Jiang J, et al. Among authors: hou f. Zhonghua Nei Ke Za Zhi. 2001 Jan;40(1):25-8. Zhonghua Nei Ke Za Zhi. 2001. PMID: 11798554 Chinese.

3

[Comparison of two score models in predicting prognosis and renal outcome in acute renal failure].

Zhang W, Zhang X, Hou F, Chen P. Zhang W, et al. Among authors: hou f. Zhonghua Nei Ke Za Zhi. 2002 Nov;41(11):769-72. Zhonghua Nei Ke Za Zhi. 2002. PMID: 12485526 Chinese.

4

Efficacy and safety of benazepril for advanced chronic renal insufficiency.

Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, Jiang JP, Liang M, Wang GB, Liu ZR, Geng RW. Hou FF, et al. N Engl J Med. 2006 Jan 12;354(2):131-40. doi: 10.1056/NEJMoa053107. N Engl J Med. 2006. PMID: 16407508 Free article. Clinical Trial.

5

Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation.

Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZQ, Zhou ZM, Zhou M, Xie D, Wang GB, Zhang X. Liu SX, et al. Arterioscler Thromb Vasc Biol. 2006 May;26(5):1156-62. doi: 10.1161/01.ATV.0000214960.85469.68. Epub 2006 Feb 23. Arterioscler Thromb Vasc Biol. 2006. PMID: 16497990

6

Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model.

Li HY, Hou FF, Zhang X, Chen PY, Liu SX, Feng JX, Liu ZQ, Shan YX, Wang GB, Zhou ZM, Tian JW, Xie D. Li HY, et al. J Am Soc Nephrol. 2007 Feb;18(2):528-38. doi: 10.1681/ASN.2006070781. Epub 2007 Jan 3. J Am Soc Nephrol. 2007. PMID: 17202414

7

Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model.

Feng JX, Hou FF, Liang M, Wang GB, Zhang X, Li HY, Xie D, Tian JW, Liu ZQ. Feng JX, et al. Among authors: hou ff. Kidney Int. 2007 May;71(9):901-11. doi: 10.1038/sj.ki.5002162. Kidney Int. 2007. PMID: 17342181 Free article.

8

Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency.

Hou FF, Xie D, Zhang X, Chen PY, Zhang WR, Liang M, Guo ZJ, Jiang JP. Hou FF, et al. J Am Soc Nephrol. 2007 Jun;18(6):1889-98. doi: 10.1681/ASN.2006121372. Epub 2007 May 9. J Am Soc Nephrol. 2007. PMID: 17494885 Clinical Trial.

9

Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase.

Shi XY, Hou FF, Niu HX, Wang GB, Xie D, Guo ZJ, Zhou ZM, Yang F, Tian JW, Zhang X. Shi XY, et al. Among authors: hou ff. Endocrinology. 2008 Apr;149(4):1829-39. doi: 10.1210/en.2007-1544. Epub 2008 Jan 3. Endocrinology. 2008. PMID: 18174276

10

Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway.

Guo ZJ, Niu HX, Hou FF, Zhang L, Fu N, Nagai R, Lu X, Chen BH, Shan YX, Tian JW, Nagaraj RH, Xie D, Zhang X. Guo ZJ, et al. Antioxid Redox Signal. 2008 Oct;10(10):1699-712. doi: 10.1089/ars.2007.1999. Antioxid Redox Signal. 2008. PMID: 18576917 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,714 results

Search Page

Filters